Adverse Events in Twitter-Development of a Benchmark Reference Dataset: Results from IMI WEB-RADR

Juergen Dietrich1, Lucie M Gattepaille2, Britta Anne Grum3

  • 1Pharmacovigilance, Bayer AG, Müllerstr. 170, 13353, Berlin, Germany. juergen.dietrich@bayer.com.

Drug Safety
|January 31, 2020
PubMed
Summary

Researchers created a benchmark dataset from Twitter data to evaluate automated adverse event recognition systems. This dataset aids in analyzing social media for drug safety information and improving pharmacovigilance.